On Tuesday 12th June 2018, 5 patients from United Patients Alliance attended a Press Conference for Charlotte Caldwell who’s fight to bring her son, Billy, age 12 with intractable epilepsy, his effective cannabis medicine into the UK has been so prominent in the media since her story broke on Sunday.
On the advice of our patrons and other supportive MP's and after feedback from the Met Police and with the full support of Paul Flynn we have decided to change the Patients at Parliament demonstration in support of his Elizabeth Brice Bill for Medical Cannabis on July 6th in favour of more constructive actions and initiatives.
The MS Society initially got in touch with the United Patients Alliance saying that they wanted to re-consider their position on medical cannabis use for MS patients. As someone with direct experience of the benefits cannabis can bring to MS suffers, I jumped at the chance to get round the table with the UKs biggest MS charity, and support them to [find/see] a way forward.
Currently in the UK, cannabis in its raw form, which is a comparatively recent amendment in the wording, sits in Schedule 1 of the Misuse of Drugs Act 1971 (MODA) which defines it as having no therapeutic benefit and high potential for abuse.
In addition, the two UK politicians, indeed ministers, best placed to reform our failed & archaic cannabis laws, both potentially stand to benefit financially from our booming legal cannabis industry
This is as big an ask as it is an opportunity for any patients who would like to share their story and receive the very best help and support on a specific kind of journey.
The use of cannabis for medicinal purposes is common and the evidence that it is efficacious for several medical conditions is now very strong. It is illogical to continue categorising the drug under Schedule 1 of the Misuse of Drugs Regulations.
Well it was certainly a big disappointment that Paul Flynn's #ElizabethBriceBill didn't even get a reading, however it did get a new date. So what happened? Why did this happen? What's next?
We are and always will be a peaceful organisation that calls on patients to tell their story and to inform and educate both the public and the authorities. We want everyone to feel safe attending our events. We will always strive to defend patients detained whilst medicating on their way to or from the event, or victims of random stop and searches. At last year's Green Pride event (hosted by Brighton Cannabis Club) several individuals were arrested for possession and fined, and we were able to raise the money to pay their fines within a matter of days. We don't believe anyone should be arrested for cannabis possession.
So here we are again for the second reading of Paul Flynn's #ElizabethBriceBill for the Legalisation of Cannabis (Medicinal Purposes) Bill 2017-19 on February 23rd 2018.
United Patients Alliance, in collaboration with our Patron, Paul Flynn MP will be hosting Patients at Parliament 2 another protest event to support the bill and, of course, hope that this will bring the same kind of success as the first on October 10th 2017.
I spoke at some length with Paul Flynn on Friday and can now update you all on what we can expect
Most people will know that controlled drugs fall under difference Classes (A, B or C) in the UK, but what far fewer people are aware of is that drugs are also classified under different Schedules, which restrict their availability, how they are used and whether they can be researched or prescribed. Over the coming weeks, VolteFace will be exploring what impact the impact is of different schedules, and what could be gained from rescheduling drugs.
Jonathan, Sarah and Henry had a great day visiting Medipen at their Labs in Cardiff with the goal of learning all about what they do, who they are and what plans they have for the future.
We were all pretty impressed with their lab, their new and improved Medipen along with a wider variety of products that they sell through their retail brand: Cannassential
Miles, Nathan and I met up in the Old Vic Pub, where I used work around 28 years ago (hasn't changed!) for a bit of courage and preparation, just across the road from Lancashire County Hall where we were about to meet the Lancashire Safeguarding Children Board after reports of their Bitesize Briefing - Understanding the effects and risks of cannabis use appeared in the press a couple of weeks ago.
Our mission is to create an environment where individuals can source premium quality health products with confidence. Savage Cabbage will conduct business with passion and integrity, and continue to research and share our findings with our customers as a community.
“I know that CBD can save many lives.” Candida Lycett Green
My mother who died from cancer and complications with her chemo port in August 2014, wrote that to me in the weeks leading up to her death. That day we started MMJ with the principal aim of raising awareness to the true medicinal properties of the Cannabis Sativa L plant.
Jon Liebling (Political Director) and Gavin Sathianathan (Trustee) of United Patients Alliance met with Chris Tovey (Chief Operations Officer) (Far right in photo) and Giles Moss (Chief Product Marketing Strategist) at a coffee shop in central London - Nothing clandestine about it - just a coffee and a good chat about the world according to GW and how it differs from UPAs - we did find a couple of things we all agree on.
A response to Susannah Taylor’s article in The Times Weekend supplement on Saturday November 11th 2017
Trigger and Content Warnings: Drugs, Eating Disorders, Depression, Anxiety, Psychosis, Racism, Sexism, Violence.
2789 words, approx 14 mins reading time.
Cannabis oil F.A.Q's & advice for beginners.
Check out what's happening, and when.
Professor Mike Barnes is Honorary Professor of Neurological Rehabilitation.He is also currently Clinical Director of The Christchurch Group.He has previously been Founder President of the World Federation for NeuroRehabilitation (WFNR) and is currently Treasurer. He has a long standing interest in the management of spasticity and a long term advocate of the legalisation of cannabis for medical usage.